Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mogrify Limited (CEO: Darrin M. Disley, Ph.D., "Mogrify®"), a biopharmaceutical company transforming the lives of patients through a novel...
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, announces that the first-in-human
Investegate announcements from Avacta Group PLC, Result of Annual General Meeting
Expansion of European business development team supports next phase of growth for Metrion's ion channel drug discovery services Metrion Biosciences Limited ("Metrion"), the specialist ion channel